AIDX HEALWELL AI INC

HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer

HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer

  • Experienced finance and technology executive Anthony Lam joins as the Company’s new Chief Financial Officer.

  • Mr. Lam will replace Mr. Scott Nirenberski who has been CFO since Sept 2020.

TORONTO, June 04, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the appointment of Anthony Lam as Chief Financial Officer (CFO), effective immediately. Reporting directly to Dr. Alexander Dobranowski, CEO of HEALWELL, Mr. Lam will have responsibility for all finance, accounting, financial reporting, audit, tax, and capital planning functions. Mr. Lam assumes the Chief Financial Officer role from Scott Nirenberski who has been the company’s CFO for the past 4 years.

Dr. Alexander Dobranowski, CEO of HEALWELL, commented, “We are both thrilled and proud to welcome Anthony to HEALWELL’s executive team. Anthony’s previous financial experience as the CFO of multiple private and publicly listed technology companies will be a valuable asset to the company as we enter HEALWELL’s next stage of growth. I also want to thank Scott Nirenberski, who served as our CFO since September 2020 and helped support the transition from the predecessor company MCI OneHealth to the launch of HEALWELL in October 2023. We are very appreciative for Scott’s years of service and support and wish him well in his future endeavors.”

Anthony Lam is an Executive Business Leader with over 20 years of international senior finance and operational leadership experience in several high growth public and private organizations spanning Cybersecurity, Digital Health, Digital Media, Loyalty, SaaS, Software, Gaming, Internet Commerce and Technology Licensing sectors. With a long-standing background in analytics, treasury and capital markets, Anthony’s list of accomplishments includes successful mergers and acquisition activity, debt and capital fundraising and public listings on the Toronto, London, and NASDAQ exchanges.

Previously, Mr. Lam worked as the CFO of multiple private and publicly listed technology companies. Most recently he was the CFO of eSentire, a cybersecurity company protecting the critical data and applications of 2000+ organizations, and the CFO of Newtopia, a publicly listed technology-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. Previously, Mr. Lam was also the CFO of TSX and Nasdaq listed company, Points.com. Mr. Lam is a CPA and holds a Bachelor of Commerce degree from the University of Toronto.

Mr. Lam commented, “I am pleased to be joining the HEALWELL team and excited to help the company in its goal of improving healthcare through the early identification and detection of disease. I was drawn to HEALWELL because of the exceptional team and the opportunity to be a part of a rapidly growing company implementing AI into the healthcare sector. I'm focused on building resilient organizations, rooted with firm financial discipline, leveraging technology to improve efficiency and a continuous desire to inspire exceptional performance. I look forward to working with the HEALWELL team as we look to achieve new milestones in the years ahead.”

Dr. Alexander Dobranowski

Chief Executive Officer

HEALWELL AI Inc.

About HEALWELL AI

HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit

Forward-Looking Statements

Certain statements in this press release, constitute "forward-looking information" and "forward looking statements" (collectively, "forward looking statements") within the meaning of applicable Canadian securities laws, such as the appointment and responsibilities of the new Chief Financial Officer of the Company, and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as “effective”, “pursue”, “goal”, “build”, “leverage”, “desire”, “inspire”, “achieve”, "improve", "future", "plan", "opportunities", or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: changes in personnel and senior management, the stability of general economic and market conditions; HEALWELL's ability to comply with applicable laws and regulations; HEALWELL's continued compliance with third party intellectual property rights; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.

Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in HEALWELL's most recent annual information form dated April 1, 2024, which is available under HEALWELL's SEDAR+ profile at The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.

For more information:

Pardeep S. Sangha

Investor Relations, HEALWELL AI Inc.

Phone: 604-572-6392



EN
04/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HEALWELL AI INC

 PRESS RELEASE

EQS-News: HEALWELL-Tochter “VeroSource” enthüllt Digital-Twin-Technolo...

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Expansion/Finanzierung HEALWELL-Tochter “VeroSource” enthüllt Digital-Twin-Technologie und bereichert das Gesundheitsmanagement mit Information in Echtzeit 26.02.2025 / 12:46 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. - “VeroSource” unterstützt seine VS-Data-as-a-Service-Plattform mit einer hochmodernen Digital-Twin-Technologie und ermöglicht damit Echtzeiterkenntnisse und fortschrittliche Datenvisualisierungen für optimierte Abläufe im Ges...

 PRESS RELEASE

EQS-News: Neueste Updates zu Khure Health von HEALWELL:

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Expansion/Marktbericht Neueste Updates zu Khure Health von HEALWELL: 24.02.2025 / 20:40 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Neueste Updates zu Khure Health von HEALWELL: Signifikante Beschleunigung der Akzeptanz des KI-gestützten Co-Piloten zur Krankheitserkennung durch Nutzer und Life-Sciences-Partner und sehr gute NPS-Werte bei Ärzten - Im 4. Quartal 2024 unterstützte die Tochtergesellschaft von HEALWELL, Khure Health (Khure), mit ...

 PRESS RELEASE

EQS-News: HEALWELL übernimmt Kontrolle über “Mutuo Health Solutions” z...

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Firmenzusammenschluss/Expansion HEALWELL übernimmt Kontrolle über “Mutuo Health Solutions” zur Entwicklung der nächsten Generation von KI-gestützten Co-Piloten für die Ärzteschaft. 03.12.2024 / 17:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HEALWELL übernimmt Kontrolle über “Mutuo Health Solutions” zur Entwicklung der nächsten Generation von KI-gestützten Co-Piloten für die Ärzteschaft. - HEALWELL hat eine kontrollierende Mehrheitsbeteili...

 PRESS RELEASE

EQS-News: HEALWELL-Tochter “VeroSource Solutions” informiert in ihrem ...

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Expansion/Finanzierung HEALWELL-Tochter “VeroSource Solutions” informiert in ihrem Unternehmens-Update über rasches Wachstum und neue Kunden im öffentlichen Sektor Kanadas 27.11.2024 / 15:19 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. - Mehr als 600.000 Einwohner der kanadischen Provinz New Brunswick sind nun berechtigt, das Service der Patientenkurzübersicht (“Patient Summary”) über das von “VeroSource” eingerichtete digitale Gesundheitspor...

 PRESS RELEASE

EQS-News: HEALWELL AI begrüßt Beatrice York, Dr. Marcel Reichart und R...

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Expansion/Personalie HEALWELL AI begrüßt Beatrice York, Dr. Marcel Reichart und Reeva Misra in seinem “Strategic Advisory Board” 19.11.2024 / 15:50 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HEALWELL AI begrüßt Beatrice York, Dr. Marcel Reichart und Reeva Misra in seinem “Strategic Advisory Board” - HEALWELL AI kündigt die Gründung eines “Strategic Advisory Board” an, der die globalen Wachstumsinitiativen des Unternehmens unterstützen sowie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch